SecBot SecBot
SECBOTREPLAY Home › Report › AXSM

AXSM · Axsome Therapeutics is holding its 2026 annual meeting for shareholders…

Axsome Therapeutics, Inc. · DEFA14A filed Apr 24, 2026 at 17:02 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 24, 2026 at 17:02 ET

Axsome Therapeutics is holding its 2026 annual meeting for shareholders to vote on director elections, auditor ratification, and executive compensation. This is a routine annual governance filing with no material financial or strategic changes disclosed.

  • Annual shareholder meeting scheduled for June 5, 2026
  • Voting on election of two directors: Mark Saad and Susan Mahony
  • Ratification of Deloitte & Touche LLP as independent auditor
  • Advisory vote on executive compensation

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access